ACQ Bure AB
F:0FE
ACQ Bure AB
F:0FE
Price:
5.66
EUR
-3.82%
Market Cap:
€487.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
ACQ Bure AB
F:0FE
|
SE |
|
Nanobiotix SA
LSE:0QAV
|
FR |
Cash Flow Statement
Cash Flow Statement
ACQ Bure AB
ACQ Bure AB
Currency: SEK
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | Mar-2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||
| Net Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
336
|
462
|
531
|
541
|
287
|
167
|
129
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
33
|
0
|
0
|
0
|
36
|
0
|
0
|
0
|
35
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
90
|
0
|
|
| Other Non-Cash Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
172
|
61
|
194
|
319
|
(22)
|
31
|
0
|
(82)
|
123
|
116
|
0
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
21
|
55
|
78
|
84
|
97
|
117
|
107
|
108
|
108
|
75
|
|
| Change in Working Capital |
(7)
|
(28)
|
(19)
|
(16)
|
(16)
|
10
|
(11)
|
1
|
(161)
|
(155)
|
(141)
|
(255)
|
(185)
|
(143)
|
(96)
|
(78)
|
(63)
|
18
|
|
| Cash from Operating Activities |
(7)
N/A
|
(28)
-303%
|
(19)
+33%
|
(16)
+15%
|
(16)
+1%
|
10
N/A
|
(11)
N/A
|
103
N/A
|
114
+11%
|
125
+9%
|
263
+112%
|
215
-18%
|
344
+60%
|
355
+3%
|
363
+2%
|
332
-9%
|
254
-23%
|
297
+17%
|
|
| Investing Cash Flow | |||||||||||||||||||
| Capital Expenditures |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
(59)
|
0
|
0
|
0
|
(44)
|
0
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3 415
|
3 424
|
3 406
|
3 390
|
(24)
|
(1)
|
(59)
|
(56)
|
(66)
|
(4)
|
(58)
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
3 415
N/A
|
3 411
0%
|
3 406
0%
|
3 390
0%
|
(24)
N/A
|
(60)
-155%
|
(59)
+1%
|
(56)
+5%
|
(66)
-18%
|
(48)
+27%
|
(58)
-20%
|
|
| Financing Cash Flow | |||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
573
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(88)
|
0
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(30)
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
(13)
|
0
|
|
| Other |
3 429
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
(3 240)
|
(3 803)
|
(3 267)
|
(3 274)
|
(42)
|
(22)
|
(20)
|
(17)
|
(101)
|
(1)
|
(100)
|
|
| Cash from Financing Activities |
3 429
N/A
|
(1)
N/A
|
(1)
+50%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(3 240)
N/A
|
(3 259)
-1%
|
(3 267)
0%
|
(3 274)
0%
|
(42)
+99%
|
(22)
+48%
|
(20)
+11%
|
(17)
+12%
|
(101)
-492%
|
(102)
-1%
|
(100)
+2%
|
|
| Change in Cash | |||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
(2)
|
13
|
16
|
(3)
|
15
|
(6)
|
(23)
|
(17)
|
(33)
|
(11)
|
|
| Net Change in Cash |
3 422
N/A
|
(30)
N/A
|
(20)
+34%
|
(16)
+18%
|
(16)
+1%
|
10
N/A
|
(11)
N/A
|
285
N/A
|
264
-8%
|
276
+5%
|
396
+44%
|
146
-63%
|
277
+89%
|
270
-2%
|
267
-1%
|
147
-45%
|
71
-52%
|
129
+81%
|
|
| Free Cash Flow | |||||||||||||||||||
| Free Cash Flow |
(7)
N/A
|
(28)
-303%
|
(19)
+33%
|
(16)
+15%
|
(16)
+1%
|
10
N/A
|
(11)
N/A
|
103
N/A
|
101
-2%
|
125
+23%
|
263
+112%
|
215
-18%
|
285
+33%
|
355
+25%
|
363
+2%
|
332
-9%
|
210
-37%
|
297
+42%
|
|
Switch to:
Switch to:
Continue 0FE Research
Discover More
